COMMUNIQUÉS West-GlobeNewswire

Nicox : Présentation de données sur le NCX 470 au Congrès Annuel 2024 de l’American Glaucoma Society
05/03/2024
Communiqué de presse Nicox : Présentation de données sur le NCX 470 au Congrès Annuel 2024 de l’American Glaucoma Society 5 mars 2024 – diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : [...]
Mithra announces changes to its executive management
05/03/2024
Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the termination of the [...]
Sandoz announces nominations to the Board of Directors and leadership change
05/03/2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Mathai Mammen and Michael Rechsteiner nominated to stand for election to Sandoz Board of Directors at upcoming Annual General [...]
Mithra initiates monetization process, receives bridge loan from existing lenders
05/03/2024
Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints advisors and initiates a process to monetize its assets or execute a sale of its business Mithra has entered into a new [...]
CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances
05/03/2024
CARBIOS Active, the enzymatic solution for 100% compostable PLA, added to FDA Inventory of Food Contact Substances PLA 1 packaging integrating CARBIOS Active is 100% compostable even at ambient temperatures, supporting [...]
CARBIOS Active, la solution enzymatique pour un PLA 100 % compostable, ajoutée à l'inventaire de la FDA des substances en contact avec les aliments
05/03/2024
CARBIOS Active, la solution enzymatique pour un PLA 100 % compostable, ajoutée à l'inventaire de la FDA des substances en contact avec les aliments Les emballages en PLA 1 intégrant CARBIOS Active sont 100 % compostable [...]
Ibogaine By David Dardashti To Explore Glial Cells Through EEG With Computer Tomography
05/03/2024
Ibogaine Clinic Aims for Advancement in Understanding Neurobiology MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- The Ibogaine By David Dardashti clinic is embarking on an ambitious initiative to advance knowledge and [...]
Doctor Leslie Mitchelson Joins Ibogaine By David Dardashti for EEG Experiments
05/03/2024
Quantifying Quantum Electrodynamics Through Biological Impact of Ibogaine Treatment MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- Doctor Leslie Mitchelson, a prominent biomedical engineer, has joined the team at Ibogaine By [...]
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine
05/03/2024
MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of [...]
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform
04/03/2024
MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire radioisotope production technology firm [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/03/2024
PARIS, 04 mars 2024 (GLOBE NEWSWIRE) -- (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
04/03/2024
PARIS, March 04, 2024 (GLOBE NEWSWIRE) -- (Article 223-16 of General Regulation of the French financial markets authority) Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/03/2024
SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
04/03/2024
Montrouge, France, March 4, 2024 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]
DBV Technologies présentera ses résultats financiers pour l’exercice 2023 et fera le point sur ses activités le 7 mars 2024.
04/03/2024
Montrouge, France, le 4 mars (22h30 CET) 2024 DBV Technologies présentera ses résultats financiers pour l’exercice 2023 et fera le point sur ses activités le 7 mars 2024. DBV Technologies (Euronext : DBV – ISIN : [...]
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
04/03/2024
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]
Akero Therapeutics Announces Proposed Public Offering of Common Stock
04/03/2024
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked [...]
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
04/03/2024
PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced today that it [...]
Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting
04/03/2024
New data advances understanding of new approaches to treating Alzheimer’s disease Research on disease progression could help inform future clinical trials CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Biogen Inc [...]

Pages